Item 8.01 Other Events.

On January 3, 2023, Chemomab Therapeutics Ltd. issued a press release announcing the top-line results from its CM-101 Phase 2a liver fibrosis biomarker trial in NASH patients.

A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits

Exhibit
Number     Description
  99.1       Press release dated January 3, 2023
104        Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses